Voglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg - Explore......

TRIOGLIMITERIS 1/0.2 

Voglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg

Introduction

TRIOGLIMITERIS 1/0.2 is a combination medication that contains Voglibose 0.2 mg, Glimepiride 1 mg, and Metformin Hydrochloride 500 mg. This powerful combination is used to manage type 2 diabetes mellitus, offering a multifaceted approach to control blood sugar levels. Each component of this medication works in synergy to provide effective glycemic control, making it a preferred choice for many healthcare providers. This article will explore the uses, dosage, side effects, and price, and provide a comprehensive conclusion about TRIOGLIMITERIS 1/0.2.

Uses

TRIOGLIMITERIS 1/0.2 is primarily prescribed for the management of type 2 diabetes mellitus. Each active ingredient plays a crucial role in controlling blood sugar levels:

1. Voglibose (0.2 mg): Voglibose is an alpha-glucosidase inhibitor that slows down the absorption of carbohydrates in the intestines. This helps in preventing a rapid rise in blood glucose levels post-meals.

2. Glimepiride (1 mg): Glimepiride is a sulfonylurea that stimulates the release of insulin from the pancreatic beta cells. This increase in insulin helps lower blood glucose levels.

3. Metformin Hydrochloride (500 mg): Metformin is a biguanide that works by decreasing glucose production in the liver and improving insulin sensitivity in muscle and fat tissues, allowing better glucose uptake and utilization.

Together, these three components help in achieving better glycemic control by targeting different mechanisms involved in blood sugar regulation.

Dosage

The dosage of TRIOGLIMITERIS 1/0.2 should be individualized based on the patient's medical condition, response to treatment, and blood glucose levels. It is crucial to follow the healthcare provider's instructions for optimal results.

General Dosage Guidelines:

1. Initial Dose: Typically, one tablet is taken once or twice daily with meals to reduce gastrointestinal side effects and enhance drug absorption.
2. Adjustments: The dosage may be adjusted based on regular monitoring of blood glucose levels and the patient's tolerance to the medication.
3. Maximum Dose: Do not exceed the maximum prescribed dose without consulting a healthcare provider.

Important Dosage Instructions:

• Consistent Timing: Take the medication simultaneously each day to maintain consistent blood levels.
• Missed Dose: If a dose is missed, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose and resume the regular schedule. Do not double the dose to make up for the missed one.
• Diet and Exercise: Combine the medication with a balanced diet and regular physical activity for better glycemic control.

Side Effects

Like all medications, TRIOGLIMITERIS 1/0.2 may cause side effects. While not everyone experiences them, it is important to be aware of the potential adverse effects and consult a healthcare provider if they occur.

Common Side Effects:

1. Gastrointestinal Issues: Nausea, vomiting, diarrhea, abdominal pain, and flatulence are common, especially when starting the medication.
2. Hypoglycemia: Low blood sugar levels can occur, particularly if meals are skipped or the medication is taken with other antidiabetic drugs. Symptoms include dizziness, sweating, shakiness, and confusion.

Serious Side Effects:

1. Lactic Acidosis: A rare but serious side effect of metformin, characterized by muscle pain, difficulty breathing, and unusual tiredness. 
2. Allergic Reactions: Symptoms include rash, itching, swelling, severe dizziness, and difficulty breathing. Seek immediate medical attention if any signs of an allergic reaction are observed.

Price

The price of TRIOGLIMITERIS 1/0.2 can vary depending on the region, pharmacy, and whether it is purchased as a branded or generic product. On average, the cost for a month's supply of TRIOGLIMITERIS 1/0.2 is approximately INR 600-800. It is advisable to compare prices from different pharmacies and consider purchasing in bulk to save on costs. Additionally, some health insurance plans may cover part of the expense, so it is beneficial to check with the insurance provider.

Conclusion

TRIOGLIMITERIS 1/0.2, comprising Voglibose 0.2 mg, Glimepiride 1 mg, and Metformin Hydrochloride 500 mg, is an effective combination medication for managing type 2 diabetes mellitus. By targeting different pathways in blood sugar regulation, this medication provides comprehensive glycemic control. Adhering to the prescribed dosage, maintaining a healthy diet, and engaging in regular physical activity are essential for achieving optimal results. While the medication is generally well-tolerated, being aware of potential side effects and consulting a healthcare provider if they occur is important. The cost of TRIOGLIMITERIS 1/0.2 is reasonable, and considering insurance coverage or bulk purchases can help manage expenses. Overall, TRIOGLIMITERIS 1/0.2 is a valuable tool in the management of type 2 diabetes, offering hope and support to those seeking better control over their blood sugar levels. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.

For further information 

Email: info@sterispharma.com /  contact@sterispharma.com

Call/WhatsApp:  7877551268, 7849827488 

BUY NOW